

Rezitop is a medical device indicated for the treatment and prevention of the symptoms of allergic rhinitis (e.g. pollen allergy) and to facilitate the regeneration of the sensitive nasal mucosa. Typical symptoms such as sneezing, itching, runny nose and nasal congestion can be effectively reduced. Rezitop is a medical device that contains ectoine, a natural cell protection molecule with membrane stabilization and inflammation-reducing properties, which acts through a physical mechanism. Ectoine forms, with water, a hydroprotective complex that protects against the harmful effects of allergens and against dehydration of the nasal mucosa. Helps regenerate sensitive nasal mucosa. Rezitop does not contain preservatives and is very well tolerated, meaning it can be used in children, babies and newborns.
Warnings and precautions: Rezitop should not be used after nasal surgery, in nose injuries and in case of allergy (hypersensitivity) to ectoine or any of the components of the formulation. Rezitop should be immediately discontinued in case of an allergic reaction. For hygiene reasons, each bottle of nasal spray should only be used by one person.
Rezitop should be used within 6 weeks of first opening the bottle. This information does not require careful reading of the labeling and instructions for use.